论文信息 - Early Eculizumab Withdrawal in Patients With Atypical Hemolytic Uremic Syndrome in Native Kidneys Is Safe and Cost-Effective: Results of the CUREiHUS Study - 字舞流文

Early Eculizumab Withdrawal in Patients With Atypical Hemolytic Uremic Syndrome in Native Kidneys Is Safe and Cost-Effective: Results of the CUREiHUS Study

E. Adang | J. Wetzels | E. Volokhina | F. Bemelman | A. V. van Zuilen | S. Berger | A. D. de Vries | M. Keijzer-Veen | R. ter Heine | J. V. van Wijk | J. W. van der Heijden | J. van de Wetering | N. C. van de Kar | R. Bouwmeester | A. Bouts | R. V. van Rooij | E. Dorresteijn | V. Gracchi | Mendy Ter Avest | K. Wijnsma | Caroline Duineveld | C. Duineveld | L. P. van den Heuvel | Flore A. P. T. Engels | Wim Altena | Renée de Wildt | E. V. van Kempen | R. W. van Rooij